Navigation Links
Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
Date:11/12/2009

veral innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims an
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... AUSTIN, Texas , June 17, 2013  Hanger, ... new 5-year credit agreement that increases its senior secured ... from $400 million previously.  The new credit agreement includes ... million term loan facility.  The previous credit agreement was ... a $300 million term loan.  Each new facility matures ...
(Date:6/17/2013)... BioMed Realty Trust, Inc. (NYSE: BMR ) today ... quarter 2013 dividend of $0.235 per share of common stock. ... per common share. The common stock dividend ... at the close of business on June 28, 2013.  ... delivers optimal real estate solutions for biotechnology and pharmaceutical companies, ...
(Date:6/17/2013)... MOORESTOWN, N.J. , June 17, 2013 /PRNewswire-iReach/ ... of the company,s new X-4S pressure sensitive labeling ... most stringent speed and performance requirements that serialization ... close in, WLS is uniquely qualified to work ... partner in their serialization and track and trace ...
Breaking Medicine Technology:Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2
(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... a way to make phytosterol molecules from plants dispersible ... potentially opening the way to dramatic reductions in human ... new process and composition was issued on June 11. ... in animals are highly similar and when both are ... they mix in the gut of an animal, the ...
(Date:6/18/2013)... computer guided fitness training system using a person,s ... winners of the LeWeb,13 London Startup Competition, Europe,s ... startup company, Genetrainer, building on University of Bristol ... Pethica and Julian Gough, Professor of Bioinformatics in ... from over 350 startups to be one of ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Brandeis scientist invents anti-cholesterol process 2
... , FRIDAY, Dec. 2 (HealthDay News) -- ... more than doubled in the United States between 1997 ... large increase of prescriptions written at outpatient clinics is ... Dorn, an assistant professor of medicine at the University ...
... University of Nevada, Reno and licensed through the University,s ... publication "Better World Report" for a remarkable second year ... advancement that has been licensed through IMMY, a diagnostics ... save the lives of hundreds of thousands of AIDS ...
... , FRIDAY, Dec. 2 (HealthDay News) -- Major depression and ... pregnant women and new mothers, a new study indicates. ... women are and what led up to these tragic events," ... medicine at the University of Michigan Medical School, said in ...
... The American Journal of Industrial Medicine recently published a ... at more than twice the rate of the general U.S. population ... the collapse of the WTC towers in 2001. Preliminary study results ... , Past studies have documented high rates of asthma symptoms among ...
... commercial stage private oncology company, has announced that prominent ... be the first to provide access to its Tumor ... of recurrent glioblastoma multiforme (GBM). GBM is a ... , The NovoTTF device, approved by the ...
... , FRIDAY, Dec. 2 (HealthDay News) -- ,Topical treatment ... be the first line of therapy for treating psoriasis ... from the National Psoriasis Foundation Medical Board based in ... because they cause no known adverse effects. Psoriasis, ...
Cached Medicine News:Health News:Depression, Partner Conflict Raise Suicide Risk for Pregnant Women, New Moms 2Health News:Asthma rates double for WTC first responders 2Health News:Asthma rates double for WTC first responders 3Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 2Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 3Health News:New Guidelines for Treating Psoriasis When Pregnant or Nursing 2
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
... take their eyes for granted. Like ... eyes need proper nutrition and care ... vision as you age. In fact, ... to maintaining and preserving eye health ...
... The herbal extracts, vitamins, minerals, ... increases circulation to ocular tissue, ... healthy function of the lens ... This formula is optimized to ...
Online Unity Interlaboratory QC Data Management...
Medicine Products: